CCR5 Expression on Cells from HLA-Matched Unrelated Marrow Donors and Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 1, 2010, Pages 132-133

  Ma, Qing ^a   Gooley, Ted A ^a   Storb, Rainer F ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HOMOZYGOTE; HUMAN; LETTER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ALLELES; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HOMOZYGOTE; HUMANS; LIVING DONORS; MALE; MIDDLE AGED; RECEPTORS, CCR5; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72649100969     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.05.017     Document Type: Letter

References (10)

1. Luther S.A., and Cyster J.G. Chemokines as regulators of T cell differentiation. Nat Immunol 2 (2001) 102-107
2. Hancock W.W. Chemokine receptor-dependent alloresponses. Immunol Rev 196 (2003) 37-50
3. + T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest 104 (1999) 49-57
4. + T cells to the liver, lung, and spleen during graft-versus-host disease. Blood 96 (2000) 2973-2980
5. Murai M., Yoneyama H., Ezaki T., et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol 4 (2003) 154-160
6. Smith M.W., Dean M., Carrington M., et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277 (1997) 959-965
7. Smith M.W., Dean M., Carrington M., Huttley G.A., and O'Brien S.J. CCR5-delta 32 gene deletion in HIV-1 infected patients. Lancet 350 (1997) 741
8. Fischereder M., Luckow B., Hocher B., et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 357 (2001) 1758-1761
9. Hansen J.A., Gooley T.A., Martin P.J., et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338 (1998) 962-968
10. Dhami H., Fritz C.E., Gankin B., et al. The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies. J Clin Pharm Ther 34 (2009) 147-160